TSX Ends On Weak Note After Cautious Session
After seeing a brief spell in positive territory Wednesday morning, the Canadian market drifted down into the red and stayed weak till the end of the session, due largely to sustained selling in cannabis and industrials shares.
Source: RTTNews
NRx Pharmaceuticals (Nasdaq: NRXP): FDA Declines Emergency Use Authorization for ZYESAMI (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir




